Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment

• Published in: Rheumatic & musculoskeletal diseases open 2023-03, Vol.9 (1), p.e002663
• Main Authors: Kiltz, Uta, Hoeper, Kirsten, Hammel, Ludwig, Lieb, Sebastian, Hähle, Andreas, Meyer-Olson, Dirk
• Format: Article
• Language: English
• Subjects: Absenteeism; Age; Arthritis; Disease; Germany - epidemiology; Humans; Immune System Diseases; Maximum likelihood method; Participation; Patient Reported Outcome Measures; Patients; Population; Prevalence; Productivity; Quality of life; Questionnaires; Sick leave; Spondylitis, Ankylosing; Spondylitis, Ankylosing - drug therapy; Spondyloarthritis; Statistical analysis; Surveys and Questionnaires; Variables; Workplace
• ISSN: 2056-5933; 2056-5933
• DOI: 10.1136/rmdopen-2022-002663

IntroductionAxial spondyloarthritis (axSpA) is a chronic inflammatory disease that typically affects people in their second and third decades of life, which are important years for establishing a professional career. We aim to study outcomes of work participation (WP) and their associations with demographic and clinical confounders, in addition to prevalence of negative workplace experiences in axSpA.MethodsIn total, 770 patients with axSpA participated in the multicentre, observational ATTENTUS–axSpA survey in Germany. Demographic information, clinical parameters and patient-related outcomes (including disease activity and function) with a focus on WP were prospectively recorded.ResultsA high prevalence of negative workplace experiences was reported among the 770 patients analysed. Overall, 23.4% of patients were not employed and 6.5% received disability pensions. Current work cessation was prevalent in 120 patients, and 28 of those were out of work for 10 years or longer. Of the 590 currently employed patients, 31.9% reported absenteeism and 35.9% reported presenteeism for >1 month within the past year. Multivariate logistic regression identified low disease activity (Bath Ankylosing Spondylitis Disease Activity Index), better physical function (Bath Ankylosing Spondylitis Functional Index) and better global functioning (Assessment of SpondylAarthritis International Society–Health Index) as the main predictors for unimpaired WP (n=242). Importantly, biological treatment, disease duration, age, sex, education level and body mass index were not reliable predictors.DiscussionDespite improvements in pharmacological treatment options, we still observed substantially impaired WP in patients with axSpA. These data emphasise the high unmet need for targeted strategies to provide improved medical and social care.